FUEL CELL ASSEMBLY AND METHOD FOR MAKING THE SAME
    5.
    发明申请
    FUEL CELL ASSEMBLY AND METHOD FOR MAKING THE SAME 审中-公开
    燃料电池组件及其制造方法

    公开(公告)号:WO0195407A3

    公开(公告)日:2003-03-13

    申请号:PCT/US0111764

    申请日:2001-05-08

    摘要: In a fuel cell assembly comprising at least one cell including an electrolyte layer, a pair of gas diffusion electrode layers interposing said electrolyte layer between them, and a pair of flow distribution plates (5) for defining passages (10, 11) for fuel and oxidizer gases that contact said gas diffusion electrode layers, a heater (62) and various sensors (61a, 61b and 61c) are formed at least one of the flow distribution plates so that the work needed for installing the heater and sensors is simplified. By embedding them in a substrate, the need for a complex sealing arrangement can be eliminated. In particular, if each flow distribution plate is formed by performing an etching process on a substrate, and forming the heater and sensors in succession to the step of forming each flow distribution plate, the installation of sensors and fabrication of the fuel call are simplified.

    摘要翻译: 在包括至少一个包括电解质层的电池的燃料电池组件中,在它们之间插入所述电解质层的一对气体扩散电极层和用于限定用于燃料的通道(10,11)的一对分流板(5) 与所述气体扩散电极层接触的氧化剂气体,加热器(62)和各种传感器(61a,61b和61c)形成为至少一个流量分配板,使得安装加热器和传感器所需的工作简化。 通过将其嵌入基板中,可以消除对复杂密封布置的需要。 特别地,如果通过对基板进行蚀刻处理而形成各流量分配板,并且在形成各流量分配板的步骤中连续地形成加热器和传感器,则简化了传感器的安装和燃料调用的制造。

    COMPOUNDS HAVING DOPAMINE BETA-HYDROXYLASE INHIBITORY ACTIVITY
    6.
    发明申请
    COMPOUNDS HAVING DOPAMINE BETA-HYDROXYLASE INHIBITORY ACTIVITY 审中-公开
    具有多巴胺β-羟化酶抑制活性的化合物

    公开(公告)号:WO1997029076A1

    公开(公告)日:1997-08-14

    申请号:PCT/KR1997000021

    申请日:1997-02-06

    IPC分类号: C07C233/18

    CPC分类号: C07D295/185 C07C233/18

    摘要: The present invention relates to lettusic acid derivatives of formula (I), a preparation process thereof and a pharmaceutical composition comprising same as an active ingredient. Lettusic acid or its derivative of formula (I) has a dopamine beta -hydroxylase inhibitory activity, wherein X and Y, which are the same or different, are OR1 or (II). R1 is a hydrogen atom, an optionally substituted lower alkyl group or an alkaline metal, R2 and R3 are independently a hydrogen atom or an optionally substituted lower alkyl group, or they are linked together to form a saturated or unsaturated ring having one or more N or O atoms.

    摘要翻译: 本发明涉及式(I)的乐曲酸衍生物,其制备方法和包含该活性成分的药物组合物。 乐曲酸或其式(I)的衍生物具有多巴胺β-羟化酶抑制活性,其中相同或不同的X和Y是OR 1或(II)。 R1是氢原子,任意取代的低级烷基或碱金属,R2和R3独立地是氢原子或任意取代的低级烷基,或它们连接在一起形成饱和或不饱和的环,其具有一个或多个N 或O原子。

    LIGHT EMITTING DEVICE HAVING ZENER DIODE THEREIN AND METHOD OF FABRICATING THE SAME
    7.
    发明申请
    LIGHT EMITTING DEVICE HAVING ZENER DIODE THEREIN AND METHOD OF FABRICATING THE SAME 审中-公开
    具有齐纳二极管的发光装置及其制造方法

    公开(公告)号:WO2007111432A1

    公开(公告)日:2007-10-04

    申请号:PCT/KR2007/001348

    申请日:2007-03-20

    IPC分类号: H01L33/00

    摘要: Disclosed are a light emitting device having a zener diode therein and a method of fabricating the light emitting device. The light emitting device comprises a P-type silicon substrate having a zener diode region and a light emitting diode region. A first N-type compound semiconductor layer is contacted to the zener diode region of the P-type silicon substrate to exhibit characteristics of a zener diode together with the P-type silicon substrate. Further, a second N-type compound semiconductor layer is positioned on the light emitting diode region of the P-type silicon substrate. The second N-type compound semiconductor layer is spaced apart from the first N-type compound semiconductor layer. Meanwhile, a P-type compound semiconductor layer is positioned on the second N-type compound semiconductor layer, and an active layer is interposed between the second N-type compound semiconductor layer and the P-type compound semiconductor layer. Accordingly, it is possible to provide a light emitting device having a zener diode including the P-type silicon substrate and the first N-type compound semiconductor layer, and a light emitting diode including the second N-type compound semiconductor layer, the active layer and the P-type compound semiconductor layer in a single chip, so that damage to the light emitting diode due to electrostatic discharge can be prevented.

    摘要翻译: 公开了一种其中具有齐纳二极管的发光器件和制造发光器件的方法。 发光器件包括具有齐纳二极管区域和发光二极管区域的P型硅衬底。 第一N型化合物半导体层与P型硅衬底的齐纳二极管区域接触,以与P型硅衬底一起显示齐纳二极管的特性。 此外,第二N型化合物半导体层位于P型硅衬底的发光二极管区域上。 第二N型化合物半导体层与第一N型化合物半导体层间隔开。 同时,P型化合物半导体层位于第二N型化合物半导体层上,有源层插入在第二N型化合物半导体层和P型化合物半导体层之间。 因此,可以提供具有包括P型硅衬底和第一N型化合物半导体层的齐纳二极管的发光器件和包括第二N型化合物半导体层的发光二极管,有源层 和P型化合物半导体层,从而可以防止由于静电放电而对发光二极管造成的损坏。

    GALLIUM NITRIDE-BASED COMPOUND SEMICONDUCTOR
    8.
    发明申请
    GALLIUM NITRIDE-BASED COMPOUND SEMICONDUCTOR 审中-公开
    基于氮化镓的化合物半导体

    公开(公告)号:WO2007078065A1

    公开(公告)日:2007-07-12

    申请号:PCT/KR2006/005431

    申请日:2006-12-13

    发明人: LEE, Sang Joon

    IPC分类号: H01L21/18

    摘要: The present invention relates to a gallium nitride-based compound semiconductor. The present invention provides a gallium nitride -based compound semiconductor comprising a substrate, a buffer layer containing boron and formed on the substrate, and a gallium nitride- based semiconductor layer formed on the buffer layer. The present invention further provides a method of fabricating the gallium nitride-based compound semiconductor. According to the present invention, the buffer layer containing boron is formed as a single film, a multi-layered film or a superlattice layer, thereby reducing crystal defects with respect to the semiconductor layer formed on the buffer layer and improving the crystallinity of the semiconductor layer, resulting in a semiconductor layer without crystal defects. Thus, it is possible to improve the performance and reliability of a device.

    摘要翻译: 本发明涉及氮化镓系化合物半导体。 本发明提供一种氮化镓系化合物半导体,其包含基板,形成在基板上的含有硼的缓冲层和在缓冲层上形成的氮化镓系半导体层。 本发明还提供一种制造氮化镓基化合物半导体的方法。 根据本发明,含有硼的缓冲层形成为单一膜,多层膜或超晶格层,从而减少相对于形成在缓冲层上的半导体层的晶体缺陷并提高半导体的结晶度 导致半导体层没有晶体缺陷。 因此,可以提高装置的性能和可靠性。

    PHARMACEUTICAL PELLET COMPOSITIONS FOR CONTROLLED RELEASE
    9.
    发明申请
    PHARMACEUTICAL PELLET COMPOSITIONS FOR CONTROLLED RELEASE 审中-公开
    用于控制释放的药物颗粒组合物

    公开(公告)号:WO2005123138A1

    公开(公告)日:2005-12-29

    申请号:PCT/KR2005/000666

    申请日:2005-03-10

    IPC分类号: A61K47/30

    摘要: The present invention provides a pharmaceutical composition in the form of pellet wherein controlled release of pharmacologically active substances can be effected. The present invention is characterized by a pharmaceutical composition for controlled release pellets, consisting es¬ sentially of: a) one or more pharmacologically active substances; b) one or more lipids having a low-melting point of less than 70°C and existing as a solid at room temperature; c) one or more hydrophilic substances; and d) one or more water-insoluble binding agents, prepared without melting the lipids.

    摘要翻译: 本发明提供了丸剂形式的药物组合物,其中可以实现药理活性物质的控制释放。 本发明的特征在于用于控释丸剂的药物组合物,其包括:a)一种或多种药理活性物质; b)一种或多种低熔点小于70℃并在室温下作为固体存在的脂质; c)一种或多种亲水性物质; 和d)一种或多种不溶于脂质的水不溶性结合剂。